Oxana Denisova

Centre for Biotechnology (Turku Centre for Biotechnology)


Turku Centre for Biotechnology

Areas of expertise
Cancer cell signaling; kinases; protein phosphatase 2A; anticancer and antiviral agents, virus-host interaction


Education and degrees completed

Ph.D. in Medicine (Molecular Virology) 26th August 2014, at
the Faculty of Medicine, University
of Helsinki, Finland. Topic: "Influenza
virus-host interactions and their modulation by small molecules".

in Biology
(Molecular Biology) (Hons.) 29th June
2007, at Lobachevsky State University of Nizhny Novgorod, Russia. Topic: "Development of genomic approach for
high-throughput analysis of CCWGG methylation".

Training at the Molecular Biology Education centre, 09.2005 – 05.2007,
Institute of Protein Research, Pushchino, Russia, included in MSc degree. Topic:
"Cloning and purification of
site-specific endonuclease EcoRIIC".


Postdoctoral researcher at Turku Centre for Biotechnology, University
of Turku and Åbo Academi, Turku, Finland 01.2015 – present. 


Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide (2018)
International Journal of Cancer
Tor‐Christian Johannessen, Md Mahdi Hasan‐Olive, Huaiyang Zhu, Oxana Denisova, Amra Grudic, Md Abdul Latif, Halala Saed, Jobin K. Varughese, Gro Vatne Røsland, Ning Yang, Terje Sundstrøm, Anne Nordal, Karl Johan Tronstad, Jian Wang, Morten Lund‐Johansen, Anne Simonsen, Bassam Janji, Jukka Westermarck, Rolf Bjerkvig, Lars Prestegarden
A1 Journal article – refereed)

PP2A inhibitor PME-1 drives kinase inhibitor resistance in glioma cells (2016)
Cancer Research
Amanpreet Kaur, Oxana V. Denisova, Xi Qiao, Mikael Jumppanen, Emilia Peuhu, Shafiq U. Ahmed, Olayinka Raheem, Hannu Haapasalo, John Eriksson, Anthony J. Chalmers, Pirjo Laakkonen, Jukka Westermarck
A1 Journal article – refereed)

Last updated on 2019-14-01 at 12:58